Report cover image

Peptide Therapeutics Market: Global Market Size, Forecast, Insights, and Competitive Landscape

Publisher Prodture
Published Sep 23, 2024
Length 131 Pages
SKU # PROD19315230

Description

Peptide Therapeutics Market: Global Market Size, Forecast, Insights, and Competitive Landscape


The global peptide therapeutics market is expected to grow at a CAGR of around 8.7% during 2025-2034. This report on global peptide therapeutics market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global peptide therapeutics market by segmenting the market based on type, manufacturer, synthesis technology, routes of administration, application and region. Also, detailed profiles of companies operating in the peptide therapeutics market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.

Market Drivers

• Rising Geriatric Population
• Increasing Prevalence of Cancer
• Technological Advancements

Market Challenges

• Poor Chemical and Physical Stability
• Presence of Stringent Safety Regulations

Historical & Forecast Period

Base Year: 2024
Historical Period: 2020-2024
Forecast Period: 2025-2034

Market by Type

• Innovative
• Generic

Market by Type by Manufacturer

• Outsourced
• In-house

Market by Synthesis Technology

• Solid Phase Peptide Synthesis
• Liquid Phase Peptide Synthesis
• Hybrid Technology

Market by Routes of Administration

• Parenteral
• Oral
• Others

Market by Routes of Application

• Gastrointestinal Disorders
• Neurological Disorders
• Metabolic Disorders
• Cancer
• Others

Market by Region

• Europe
Germany
United Kingdom
France
Italy
Spain
Russia
Netherlands
Rest of Europe
• North America
United States
Canada
• Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Rest of Asia Pacific
• Latin America
Mexico
Brazil
Argentina
Rest of Latin America
• Middle East & Africa
Saudi Arabia
Turkey
Iran
United Arab Emirates
Rest of Middle East & Africa

Table of Contents

131 Pages
1. Preface
1.1 Objective
1.2 Target Audience & Key Offerings
1.3 Report’s Scope
1.4 Research Methodology
1.4.1 Phase I
1.4.2 Phase II
1.4.3 Phase III
1.5 Assumptions
2. Key Insights
3. Global Peptide Therapeutics Market
3.1. Introduction
3.2. Market Drivers
3.3. Market Challenges
4. Global Peptide Therapeutics Market Analysis
4.1. Market Portraiture
4.2. Market Size
4.3. Market Forecast
4.4. Impact of COVID-19
5. Global Peptide Therapeutics Market by Type
5.1. Introduction
5.2. Innovative
5.3. Generic
6. Global Peptide Therapeutics Market by Type of Manufacturer
6.1. Introduction
6.2. Outsourced
6.3. In-house
7. Global Peptide Therapeutics Market by Synthesis Technology
7.1. Introduction
7.2. Solid Phase Peptide Synthesis
7.3. Liquid Phase Peptide Synthesis
7.4. Hybrid Technology
8. Global Peptide Therapeutics Market by Routes of Administration
8.1 Introduction
8.2 Parenteral
8.3 Oral
8.4 Others
9. Global Peptide Therapeutics Market Application
9.1. Gastrointestinal Disorders
9.2. Neurological Disorders
9.3. Metabolic Disorders
9.4. Cancer
9.5. Others
10. Global Peptide Therapeutics Market by Region
10.1 Introduction
10.2 Europe
10.2.1 Germany
10.2.2 United Kingdom
10.2.3 France
10.2.4 Italy
10.2.5 Spain
10.2.6 Russia
10.2.7 Netherlands
10.2.8 Rest of the Europe
10.3 North America
10.3.1 United States
10.3.2 Canada
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 South Korea
10.4.5 Australia
10.4.6 Indonesia
10.4.7 Rest of the Asia Pacific
10.5 Latin America
10.5.1 Mexico
10.5.2 Brazil
10.5.3 Argentina
10.5.4 Rest of Latin America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 Turkey
10.6.3 Iran
10.6.4 United Arab Emirates
10.6.5 Rest of Middle East & Africa
11. SWOT Analysis
12. Porter’s Five Forces
13. Market Value Chain Analysis
14. Competitive Landscape
14.1. Competitive Scenario
14.2. Company Profiles
14.2.1. Amgen Inc.
14.2.2. Apitope International NV
14.2.3. Arch Biopartners Inc.
14.2.4. AstraZeneca plc
14.2.5. Circle Pharma Inc.
14.2.6. Corden Pharma GmbH
14.2.7. F. Hoffmann-La Roche AG
14.2.8. Ipsen Group
14.2.9. Lonza Group AG
14.2.10. Novo Nordisk A/S
14.2.11. Pfizer Inc.
14.2.12. Teva Pharmaceuticals Industries Ltd.
14.2.13. Zealand Pharma A/S.
List of Figures
Figure 1: Global Peptide Therapeutics Market (in US$ Million), 2020-2024
Figure 2: Global Peptide Therapeutics Market by Type, 2024
Figure 3: Global Peptide Therapeutics Market by Manufacturer, 2024
Figure 4: Global Peptide Therapeutics Market by Synthesis Technology, 2024
Figure 5: Global Peptide Therapeutics Market by Routes of Administration, 2024
Figure 6: Global Peptide Therapeutics Market by Application, 2024
Figure 7: Global Peptide Therapeutics Market by Region, 2024
Figure 8: Global Peptide Therapeutics Market (in US$ Million), 2025-2034
Figure 9: Global Peptide Therapeutics Market by Type (in %), 2024 & 2034
Figure 10: Global Innovative Peptide Therapeutics Market(in US$ Million), 2020-2024
Figure 11: Global Innovative Peptide Therapeutics Market(in US$ Million), 2025-2034
Figure 12: Global Generic Peptide Therapeutics Market(in US$ Million), 2020-2024
Figure 13: Global Generic Peptide Therapeutics Market(in US$ Million), 2025-2034
Figure 14: Global Peptide Therapeutics Market by Manufacturer (in %), 2024 & 2034
Figure 15: Global Outsourced Peptide Therapeutics Market (in US$ Million), 2020-2024
Figure 16: Global Outsourced Peptide Therapeutics Market (in US$ Million), 2025-2034
Figure 17: Global In-house Peptide Therapeutics Market (in US$ Million), 2020-2024
Figure 18: Global In-house Peptide Therapeutics Market (in US$ Million), 2025-2034
Figure 19: Global Peptide Therapeutics Market by Synthesis Technology (in %), 2024 & 2034
Figure 20: Global Solid Phase Peptide Synthesis Peptide Therapeutics Market (in US$ Million), 2020-2024
Figure 21: Global Solid Phase Peptide Synthesis Peptide Therapeutics Market (in US$ Million), 2025-2034
Figure 22: Global Liquid Phase Peptide Synthesis Peptide Therapeutics Market (in US$ Million), 2020-2024
Figure 23: Global Liquid Phase Peptide Synthesis Peptide Therapeutics Market (in US$ Million), 2025-2034
Figure 24: Global Hybrid Technology Peptide Therapeutics Market (in US$ Million), 2020-2024
Figure 25: Global Hybrid Technology Peptide Therapeutics Market (in US$ Million), 2025-2034
Figure 26: Global Peptide Therapeutics Market by Routes of Administration (in %), 2024 & 2034
Figure 27: Global Parenteral Peptide Therapeutics Market (in US$ Million), 2020-2024
Figure 28: Global Parenteral Peptide Therapeutics Market (in US$ Million), 2025-2034
Figure 29: Global Oral Peptide Therapeutics Market (in US$ Million), 2020-2024
Figure 30: Global Oral Peptide Therapeutics Market (in US$ Million), 2025-2034
Figure 31: Global Other Routes of Administration Peptide Therapeutics Market(in US$ Million), 2020-2024
Figure 32: Global Other Routes of Administration Peptide Therapeutics Market(in US$ Million), 2025-2034
Figure 33: Global Peptide Therapeutics Market by Routes of Application (in %), 2024 & 2034
Figure 34: Global Gastrointestinal Disorders Peptide Therapeutics Market(in US$ Million), 2020-2024
Figure 35: Global Gastrointestinal Disorders Peptide Therapeutics Market(in US$ Million), 2025-2034
Figure 36: Global Neurological Disorders Peptide Therapeutics Market(in US$ Million), 2020-2024
Figure 37: Global Neurological Disorders Peptide Therapeutics Market(in US$ Million), 2025-2034
Figure 38: Global Metabolic Disorders Peptide Therapeutics Market(in US$ Million), 2020-2024
Figure 39: Global Metabolic Disorders Peptide Therapeutics Market (in US$ Million), 2025-2034
Figure 40: Global Cancer Peptide Therapeutics Market (in US$ Million), 2020-2024
Figure 41: Global Cancer Peptide Therapeutics Market (in US$ Million), 2025-2034
Figure 42: Global Other Applications Peptide Therapeutics Market (in US$ Million), 2020-2024
Figure 43: Global Other Applications Peptide Therapeutics Market (in US$ Million), 2025-2034
Figure 44: Global Peptide Therapeutics Market by Region (in %), 2024 & 2034
Figure 45: Europe Peptide Therapeutics Market (in US$ Million), 2020-2024
Figure 46: Europe Peptide Therapeutics Market (in US$ Million), 2025-2034
Figure 47: Europe Peptide Therapeutics Market by Country (in %), 2024 & 2034
Figure 48: Germany Peptide Therapeutics Market (in US$ Million), 2020-2034
Figure 49: United Kingdom Peptide Therapeutics Market (in US$ Million), 2020-2034
Figure 50: France Peptide Therapeutics Market (in US$ Million), 2020-2034
Figure 51: Italy Peptide Therapeutics Market (in US$ Million), 2020-2034
Figure 52: Spain Peptide Therapeutics Market (in US$ Million), 2020-2034
Figure 53: Russia Peptide Therapeutics Market (in US$ Million), 2020-2034
Figure 54: Netherlands Peptide Therapeutics Market (in US$ Million), 2020-2034
Figure 55: North America Peptide Therapeutics Market (in US$ Million), 2020-2024
Figure 56: North America Peptide Therapeutics Market (in US$ Million), 2025-2034
Figure 57: North America Peptide Therapeutics Market by Country (in %), 2024 & 2034
Figure 58: United States Peptide Therapeutics Market (in US$ Million), 2020-2034
Figure 59: Canada Peptide Therapeutics Market (in US$ Million), 2020-2034
Figure 60: Asia Pacific Peptide Therapeutics Market (in US$ Million), 2020-2024
Figure 61: Asia Pacific Peptide Therapeutics Market (in US$ Million), 2025-2034
Figure 62: Asia Pacific Peptide Therapeutics Market by Country (in %), 2024 & 2034
Figure 63: China Peptide Therapeutics Market (in US$ Million), 2020-2034
Figure 64: Japan Peptide Therapeutics Market (in US$ Million), 2020-2034
Figure 65: India Peptide Therapeutics Market (in US$ Million), 2020-2034
Figure 66: South Korea Peptide Therapeutics Market (in US$ Million), 2020-2034
Figure 67: Australia Peptide Therapeutics Market (in US$ Million), 2020-2034
Figure 68: Indonesia Peptide Therapeutics Market (in US$ Million), 2020-2034
Figure 69: Latin America Peptide Therapeutics Market (in US$ Million), 2020-2024
Figure 70: Latin America Peptide Therapeutics Market (in US$ Million), 2025-2034
Figure 71: Latin America Peptide Therapeutics Market by Country (in %), 2024 & 2034
Figure 72: Mexico Peptide Therapeutics Market (in US$ Million), 2020-2034
Figure 73: Brazil Peptide Therapeutics Market (in US$ Million), 2020-2034
Figure 74: Argentina Peptide Therapeutics Market (in US$ Million), 2020-2034
Figure 75: Middle East & Africa Peptide Therapeutics Market (in US$ Million), 2020-2024
Figure 76: Middle East & Africa Peptide Therapeutics Market (in US$ Million), 2025-2034
Figure 77: Middle East & Africa Peptide Therapeutics Market by Country (in %), 2024 & 2034
Figure 78: Saudi Arabia Peptide Therapeutics Market (in US$ Million), 2020-2034
Figure 79: Turkey Peptide Therapeutics Market (in US$ Million), 2020-2034
Figure 80: Iran Peptide Therapeutics Market (in US$ Million), 2020-2034
Figure 81: UAE Peptide Therapeutics Market (in US$ Million), 2020-2034
Figure 82: Market Value Chain
List of Tables
Table 1: Global Peptide Therapeutics Market Portraiture
Table 2: Global Peptide Therapeutics Market by Type (in US$ Million), 2024 & 2034
Table 3: Global Peptide Therapeutics Market by Manufacturer (in US$ Million), 2024 & 2034
Table 4: Global Peptide Therapeutics Market by Synthesis Technology (in US$ Million), 2024 & 2034
Table 5: Global Peptide Therapeutics Market by Routes of Administration (in US$ Million), 2024 & 2034
Table 6: Global Peptide Therapeutics Market by Application (in US$ Million), 2024 & 2034
Table 7: Global Peptide Therapeutics Market by Region (in US$ Million), 2024 & 2034
Table 8: Europe Peptide Therapeutics Market by Country (in US$ Million), 2024 & 2034
Table 9: North America Peptide Therapeutics Market by Country (in US$ Million), 2024 & 2034
Table 10: Asia Pacific Peptide Therapeutics Market by Country (in US$ Million), 2024 & 2034
Table 11: Latin America Peptide Therapeutics Market by Country (in US$ Million), 2024 & 2034
Table 12: Middle East & Africa Peptide Therapeutics Market by Country (in US$ Million), 2024 & 2034
Table 13: List of Key Players

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us